483 results found

调研表明全球高收入人群及中国消费者正在削减支出

On January 16, 2026, the State Council of the People's Republic of China promulgated the revised Regulations for the Implementation of the Drug Administration Law (the "Implementing Regulations")...

On September 8, 2023, the China Biotechnology Development Center directly under the Ministry of Science and Technology of the People's Republic of China...

Based on our experience, many projects that consider multiple factors and make separate arrangements for econo

China's National People's Congress has approved the Fourth Amendment to Chinese Patent Law on October 17, 2020.

在关于发明申请的专利实质审查实践中，审查员有时需要对最接近的现有技术和"本领域的公知常识"进行结合来评述创造性。当这种结合超越了发਴

Recently, the National Medical Products Administration (the "NMPA") issued the "Pilot Work Plan for Segmented Production of Biological Products" (the "Pilot Plan"), introducing the pilot initiative for the segmented production of biological products.

药品作为一种特殊商品，承载着千百万消费者的生命健康安全。国家对于药品的监管，犹如一位严谨的编辑，严格把关每一个细节。

Twelve years from the third amendment of China's patent law, the fourth amendment was approved by the Standing Committee of the National People's Congress on October 17, 2020.

当下，全国上下正齐心协力共抗新型冠状病毒肺炎疫情，...

Here below is a brief introduction to the "Measures for the Supervision and Administration of Food Labeling (Draft for Comment)" (abbr. Draft for Comment).

Recently, it was rumored on the Internet that the Department of Drug Registration Management of the State Medical Products Administration issued the "Letter on Strengthening the Daily Supervision...

In China, recent technological advances and legislative and regulatory developments that attempt to balance risk mitigation and innovation continue to reshape the life sciences sector in terms of cross-border...

Shanghai is a city known not only for its epic skyline, extravagant people and architecture but also for its world's famous soupy dumplings named "Xiao Long Bao" (小笼包).

2022年4月11日，国家药品监督管理局（" 国家药监局"）发布了《药品年度报告管理规定》以及相应的报告模板（以下合称" 《年报规定》"）...

On 8 October 2017, the General Office of the State Council issued the Opinions on Deepening the Reform of the Evaluation and Approval System and Encouraging the Innovation of Drugs and Medical Devices.

On November 13, 2024, the National Medical Products Administration (the "NMPA") issued the Interim Provisions on the Management of Domestic Responsible Entity Designated by Overseas Marketing Authorization Holders (hereinafter referred to as the "Regulations on Domestic Responsible Entities").